Survodutide 10 mg

$100.00

Drug Class: Dual GLP-1/Glucagon Receptor Agonist
Active Substance: Survodutide
Strength: 10 mg/vial
Amount: 2 mL Vial (Lyophilized Powder)
Active Life: ~4–5 days
Average Dose: 2.5–10 mg per week
Manufacturer: Dragon Pharma

Our Online Store

dragon pharma store

Survodutide 10 mg Lab Test – 9.68 mg Dosage, 99.704% Purity by Dragon Pharma
Survodutide 10 mg
$100.00

Survodutide 10 mg by Dragon Pharma – Dual Receptor Peptide for Fat Loss and Appetite Control

Survodutide 10 mg by Dragon Pharma is a high-purity, research-grade injectable peptide designed to support weight management, fat loss, and metabolic regulation. Each 2 mL vial contains 10 mg of lyophilized Survodutide – a dual agonist targeting both GLP-1 and glucagon receptors, offering a powerful combination of appetite suppression and increased energy expenditure.

What Is Survodutide?

Survodutide is an investigational peptide developed to treat obesity and metabolic disorders. Its unique mechanism of action stimulates glucagon-like peptide-1 (GLP-1) receptors to reduce appetite and slow gastric emptying, while also activating glucagon receptors to increase calorie burn and promote lipolysis. This dual action makes it particularly attractive for bodybuilders and fitness enthusiasts aiming to enhance fat loss while preserving lean muscle.

According to this clinical study on Survodutide’s metabolic effects, early trials show significant weight reduction and improved body composition with minimal muscle loss.

How Survodutide Is Used in Bodybuilding

In both men and women, Survodutide is used during cutting phases, contest prep, or any cycle where fat loss and appetite regulation are priorities. Its effects on satiety allow for easier adherence to low-calorie diets, while the glucagon receptor stimulation promotes greater energy utilization, even at rest.

Example Survodutide 10 mg Cycle

  • Cycle Duration: 4–8 weeks
  • Dosage: Start with 1–2 mg per week, titrated up to 5 mg as tolerated
  • Administration: Subcutaneous injection, once or twice weekly

It is recommended to start at a low dose to assess tolerance, then gradually increase to clinical or performance-targeted levels.

Stacking Suggestions with Dragon Pharma Products

Survodutide 10 mg can be stacked with other peptides or fat-loss agents for synergistic results:

  • Semaglutide – to extend GLP-1 effects for long-term satiety
  • GW501516 – for fat oxidation and cardio performance
  • Clenbuterol – to intensify thermogenic fat loss during cutting

Lab-Test Verified Quality

Survodutide 10 mg Lab Test – 9.68 mg Content, 99.704% Purity by Dragon Pharma
Lab test conducted on September 13, 2024 confirmed 9.68 mg per vial and 99.704% purity – exceeding quality benchmarks.

Potential Side Effects

While generally well tolerated, Survodutide may cause mild side effects during early dosing, including:

  • Nausea or reduced appetite
  • Mild gastrointestinal discomfort
  • Fatigue or dizziness (usually transient)

Gradual dose escalation typically helps minimize these effects. Users are advised to stay hydrated and follow a structured diet to avoid excessive calorie restriction.

User Feedback and Experiences

Early adopters of Survodutide in the performance and wellness community report significant appetite suppression, rapid fat loss, and enhanced diet adherence. Those in physique sports note improved conditioning with minimal muscle depletion. For deeper insights, check out this collection of athlete experiences with Dragon Pharma’s dual-acting peptide blend.

Where to Buy Advanced Peptides for Fat Loss

If you’re ready to push your fat-loss strategy to the next level, this innovative GLP-1/glucagon agonist from Dragon Pharma’s research portfolio is ideal for controlled body recomposition and metabolic enhancement.

Additional information

Drug Class

Dual GLP-1/Glucagon Receptor Agonist

Active Substance

Survodutide

Strength

10 mg/vial

Presentation

2 mL Vial

Manufacturer

Dragon Pharma, Europe